Primary hyperoxaluria in infants

Manel Jellouli1, Mariem Ferjani1, Kamel Abidi1

  • 1Department of Pediatric Nephrology, Charles Nicolle Hospital, Tunis, Tunisia.

Insights

Infantile primary hyperoxaluria type-1 (PH-1) leads to rapid kidney failure in infants. Early death is common, and combined liver-kidney transplantation is essential for survival.

Area of Science:

  • Nephrology
  • Pediatric Nephrology
  • Medical Genetics

Background:

  • Infantile primary hyperoxaluria type-1 (PH-1) is a rare genetic disorder.
  • It causes rapid progression to end-stage renal disease (ESRD) in infants.
  • Limited data exists on the infantile form of PH-1.

Purpose of the Study:

  • To retrospectively analyze the clinical, biological, and radiological features of infants diagnosed with PH-1 within their first year of life.
  • To understand the disease's progression and outcomes in this specific pediatric population.

Main Methods:

  • Retrospective review of medical records of infants diagnosed with PH-1 between January 1995 and December 2013.
  • Inclusion criteria: infants diagnosed within the first 12 months of life.
  • Data collected included clinical presentation, biological markers, radiological findings, diagnostic methods, and treatment outcomes.

Main Results:

  • Fourteen infants (median age: 2 months) were included.
  • At diagnosis, 11 patients presented with ESRD, and all had nephrocalcinosis.
  • Diagnosis was confirmed via family history, crystalluria, molecular analysis, or kidney biopsy.
  • Seven of 11 patients with ESRD died; four are on peritoneal dialysis.
  • Only two patients maintained renal function, showing pyridoxine sensitivity.

Conclusions:

  • Infantile PH-1 with ESRD carries a high risk of early mortality.
  • Peritoneal dialysis is not the preferred treatment.
  • Combined liver-kidney transplantation is indicated as the mandatory treatment for affected children.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
995
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
664
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
2.2K